恒发光学(1134.HK)暗盘段大涨28%
格隆汇7月15日丨恒发光学(1134.HK)暗盘段报1.28港元,较发行价1港元升28%,暂成交209万,最新总市值6.4亿港元。
公司是一间著名的中国及香港眼镜制造商,主要通过ODM及OEM业务模式生产及销售多种光学眼镜架及太阳眼镜。提供的综合及定制服务包括产品设计及开发、原材料採购、生产、质量控制、包装及交付。公司2016年至2018年收益分别为3.17亿、3.62亿、4.21亿港元,溢利分别为4478.9万、3288.7万、3102.5万港元,2018历史市盈率16.11-19.33倍。此次公开发售获适度超额认购,相当于公开发售项下初步可供认购公开发售股份总数的约29.68倍,净筹约8070万港元,每手4,000股,7月16日上市。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.